Boston Scientific Recalls INTERA 3000 Hepatic Artery Infusion Pump
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Boston Scientific Corporation is recalling one Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump due to potential leakage along the drug pathway.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 5, 2026 and geographically references Ohio. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Boston Scientific Corporation initiated a recall due to the potential for leakage along the drug pathway from the pump through the end of the catheter.
Which Products Are Affected
The recall affects the Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, an implantable drug delivery device. One device is affected, with GTIN 00850014110147 and Serial Number 20175. Distribution was limited to the state of OH.
What You Should Do
Consumers with questions should contact Boston Scientific Corporation.
Why This Matters
The Class II recall involves a single device distributed in Ohio.
Source
FDA recall number Z-2580-2026, Event ID 99063.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (686 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 5, 2026.
Frequently Asked Questions
Common questions about this FDA recall.